Integrated Filing (Financial) for the quarter ended on 31st December, 2024
Integrated Filing (Financial)
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Titan Biotech Limited on 6ix
Earlier from Titan Biotech
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Titan Biotech Limited Press Release Feb 12 2025
- Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Result
- Unaudited Financial Result For The Quarter And Nine Months Ended On 31St December, 2024
- Titan Biotech Limited Press Release Feb 03 2025
Later from Titan Biotech
- Announcement under Regulation 30 (LODR)-Updates on Acquisition
- Titan Biotech Limited Press Release Feb 28 2025
- Closure of Trading Window
- Titan Biotech Limited Press Release Mar 25 2025
- Board Meeting Intimation for Consideration & Approval Of The Audited (Standalone & Consolidated) Financial Results For The Quarter And Financial Year Ended March 31, 2025 And Consideration Of Recommendation Of Final Dividend, If Any For The Financial
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech